FdaApplication
BLA 125317
Identifiers
- fda_app_no: BLA125317
Properties
| Property | Value |
|---|---|
| applicant_name | CSL Behring GmbH |
| application_type | BLA |
| approval_date | 2009-01-16 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RIASTAP | — | 900-1300MG | For Injection |
| RIASTAP | — | 1800-2600MG | For Injection |
2 products